0001567619-23-004548.txt : 20230306
0001567619-23-004548.hdr.sgml : 20230306
20230306193028
ACCESSION NUMBER: 0001567619-23-004548
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230302
FILED AS OF DATE: 20230306
DATE AS OF CHANGE: 20230306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PLATT PHILLIP JOHN
CENTRAL INDEX KEY: 0001668926
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37586
FILM NUMBER: 23710607
MAIL ADDRESS:
STREET 1: 5255 VIRGINIA AVE
CITY: NORTH CHARLESTON
STATE: SC
ZIP: 29406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ingevity Corp
CENTRAL INDEX KEY: 0001653477
STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800]
IRS NUMBER: 474027764
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4920 O'HEAR AVENUE
STREET 2: SUITE 400
CITY: NORTH CHARLESTON
STATE: SC
ZIP: 29405
BUSINESS PHONE: 8437402300
MAIL ADDRESS:
STREET 1: 4920 O'HEAR AVENUE
STREET 2: SUITE 400
CITY: NORTH CHARLESTON
STATE: SC
ZIP: 29405
4
1
doc1.xml
FORM 4
X0306
4
2023-03-02
0
0001653477
Ingevity Corp
NGVT
0001668926
PLATT PHILLIP JOHN
C/O INGEVITY CORPORATION
4920 O'HEAR AVE, SUITE 400
NORTH CHARLESTON
SC
29405
0
1
0
0
CAO & VP, Bus Transform Lead
Common Stock
2023-03-02
4
M
0
2288
27.90
A
10811
D
Common Stock
2023-03-02
4
S
0
2288
81.70
D
8523
D
Common Stock
2023-03-02
4
M
0
1207
53.11
A
9730
D
Common Stock
2023-03-02
4
S
0
1207
81.63
D
8523
D
Common Stock
2023-03-02
4
M
0
2363
45.04
A
10886
D
Common Stock
2023-03-02
4
S
0
2363
81.62
D
8523
D
Common Stock
2023-03-02
4
S
0
2989
81.83
D
5534
D
Employee Stock Option (right to buy)
27.90
2023-03-02
4
M
0
2288
0
D
2026-05-27
Common Stock
2288
0
D
Employee Stock Option (right to buy)
53.11
2023-03-02
4
M
0
1207
0
D
2027-02-27
Common Stock
1207
0
D
Employee Stock Option (right to buy)
45.04
2023-03-02
4
M
0
2363
0
D
2030-02-28
Common Stock
2363
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.64 to $81.73, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.65, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.60 to $81.69, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option, representing a right to purchase a total of 2,288 shares, became fully vested and exercisable on February 27, 2019.
The option, representing a right to purchase a total of 1,207 shares, became fully vested and exercisable on February 27, 2020.
The option, representing a right to purchase a total of 2,363 shares, became fully vested and exercisable on February 28, 2023.
Phillip J. Platt By: Mavis Huger as Attorney-in-Fact
2023-03-06